SIGA Technologies, Inc. (SIGA) Stock Analysis & Investment Frameworks
SIGA Technologies, Inc. (SIGA) stock analysis on Invetso. Review SIGA Technologies, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
SIGA Technologies, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
SIGA Technologies, Inc. Key Financial Metrics
- Market Cap: $224.17M
- Revenue: $94.60M
- P/E Ratio: 9.75
- ROE: -1.53%
- ROIC: -3.33%
- Dividend Yield: 19.23%
About SIGA Technologies, Inc.
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
SIGA Technologies, Inc. Investment Frameworks
Invetso analyzes SIGA Technologies, Inc. (SIGA) across the following frameworks:
- SIGA Technologies, Inc. 10Y Growth Potential
- SIGA Technologies, Inc. Scenario Analysis
- SIGA Technologies, Inc. Risks & Opportunities
- SIGA Technologies, Inc. Economic Moat
- SIGA Technologies, Inc. Business Model
- SIGA Technologies, Inc. Management
- SIGA Technologies, Inc. SWOT Analysis
- SIGA Technologies, Inc. Porter's 5 Forces
- SIGA Technologies, Inc. PESTLE Analysis
- SIGA Technologies, Inc. ESG Analysis